GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » Research & Development

Healthlead PCL (BKK:HL) Research & Development : ฿0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Healthlead PCL Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Healthlead PCL's Research & Development for the three months ended in Mar. 2024 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ฿0 Mil.

Healthlead PCL Research & Development Historical Data

The historical data trend for Healthlead PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthlead PCL Research & Development Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - - - -

Healthlead PCL Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Healthlead PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthlead PCL  (BKK:HL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthlead PCL Research & Development Related Terms

Thank you for viewing the detailed overview of Healthlead PCL's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthlead PCL (BKK:HL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » Research & Development
Comparable Companies
BKK:WINMED BKK:SMD BKK:EFORL BKK:TM MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO SHSE:600739 TSE:9987 SHSE:600056 SZSE:000028
Traded in Other Exchanges
N/A
Address
99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Website
https://www.healthleadgroup.com
Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing innovative healthcare products.